ES515057A0 - "un metodo para preparar una suspension acuosa estabilizada de oxendolona". - Google Patents

"un metodo para preparar una suspension acuosa estabilizada de oxendolona".

Info

Publication number
ES515057A0
ES515057A0 ES515057A ES515057A ES515057A0 ES 515057 A0 ES515057 A0 ES 515057A0 ES 515057 A ES515057 A ES 515057A ES 515057 A ES515057 A ES 515057A ES 515057 A0 ES515057 A0 ES 515057A0
Authority
ES
Spain
Prior art keywords
oxendolone
suspension
preparing
stabilized aqueous
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES515057A
Other languages
English (en)
Spanish (es)
Other versions
ES8403719A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES8403719A1 publication Critical patent/ES8403719A1/es
Publication of ES515057A0 publication Critical patent/ES515057A0/es
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES515057A 1981-08-18 1982-08-17 "un metodo para preparar una suspension acuosa estabilizada de oxendolona". Granted ES515057A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56129517A JPS5832899A (ja) 1981-08-18 1981-08-18 オキセンドロン水性懸濁剤

Publications (2)

Publication Number Publication Date
ES8403719A1 ES8403719A1 (es) 1984-04-01
ES515057A0 true ES515057A0 (es) 1984-04-01

Family

ID=15011450

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515057A Granted ES515057A0 (es) 1981-08-18 1982-08-17 "un metodo para preparar una suspension acuosa estabilizada de oxendolona".

Country Status (13)

Country Link
US (1) US4462996A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0072662B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5832899A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880001806B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR230730A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1176983A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3263754D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES515057A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR76258B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK23888A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8700654A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT75435B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG110187G (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4120311A1 (de) * 1991-06-20 1992-12-24 Kali Chemie Pharma Gmbh Konservierte pharmazeutische zubereitungen
US20050032811A1 (en) * 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
JP4836797B2 (ja) * 2003-10-23 2011-12-14 大塚製薬株式会社 放出制御性無菌注射アリピプラゾール製剤および方法
EP2279727A3 (en) * 2005-09-15 2011-10-05 Elan Pharma International Limited Nanoparticulate aripiprazole formulations
PL2170279T3 (pl) * 2007-07-31 2018-05-30 Otsuka Pharmaceutical Co., Ltd. Sposoby wytwarzania zawiesiny arypiprazolu i liofilizowanej formulacji

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds

Also Published As

Publication number Publication date
HK23888A (en) 1988-04-08
JPS5832899A (ja) 1983-02-25
DE3263754D1 (en) 1985-06-27
MY8700654A (en) 1987-12-31
EP0072662A2 (en) 1983-02-23
EP0072662A3 (en) 1983-08-24
US4462996A (en) 1984-07-31
ES8403719A1 (es) 1984-04-01
KR880001806B1 (ko) 1988-09-19
AR230730A1 (es) 1984-06-29
EP0072662B1 (en) 1985-05-22
PT75435A (pt) 1982-09-01
GR76258B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-08-04
PT75435B (pt) 1985-05-31
CA1176983A (en) 1984-10-30
JPS6361957B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-11-30
SG110187G (en) 1988-05-20
KR840000901A (ko) 1984-03-26

Similar Documents

Publication Publication Date Title
ES538256A0 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES510449A0 (es) Un procedimiento para la preparacion de 1,2,4-triazolonas.fenoxial-quilicas.
ES516482A0 (es) "un metodo para preprar una composicion acuosa de humo liquido".
ES509911A0 (es) "un procedimiento para preparar un compuesto de inclusion de ciclodextrina".
ES512852A0 (es) "un procedimiento para preparar nuevos derivados de la n-dihidrotiazolil-3-quinolein-carboxamida".
ES557075A0 (es) Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona.
MX158898A (es) Metodo para preparar 2,4-dini-trotolueno esencialmente puro
ES510354A0 (es) Un procedimiento para la preparacion de 2,3-dicloro-5-triclorometilpiridina.
ES514652A0 (es) "un procedimiento para preparar compuestos de cefem".
ES523501A0 (es) "un metodo para preparar derivados de 3-metilflavona".
BR8205514A (pt) Processo para a preparacao de 1,2-dicloroetano
BR8206726A (pt) Processo aperfeicoado para a preparacao de 1,2-dicloroetano
ES510624A0 (es) "un procedimiento para preparar una laca de nitrocelulosa".
ES513187A0 (es) "procedimiento para la obtencion de una suspension acuosa de carbon".
ES509131A0 (es) "un procedimiento para la preparacion de un derivado de imidazolina".
ES516184A0 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
ES515057A0 (es) "un metodo para preparar una suspension acuosa estabilizada de oxendolona".
ES515305A0 (es) "un procedimiento para la preparacion de o-alquil s,s-dialquil fosforoditioatos".
ES510908A0 (es) "un procedimiento para la preparacion de derivados de piridinona".
ES508893A0 (es) "un metodo para la preparacion de una alimentacion foliar".
ES511985A0 (es) "un metodo de preparar derivados de pirazolina".
ES531760A0 (es) Un metodo para la preparacion de 1,8-dihidroxi-10-acil-9-antronas.
ES515237A0 (es) Un procedimiento para la preparacion de una sal de amonio cuaternario.
ES517471A0 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
BR8200922A (pt) Processo para a preparacao de 1,2,-dicloroetano

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040916